Alternatively, if enough tumor tissue is available and morphology has an atypical phenotype (e.g., pleomorphic or giant cell-rich tumors), KRAS mutation analysis can be performed, as independently of their morphology, the vast majority of PC harbor KRAS mutations. Here, KRAS is linked to neoplasm.